Form 4: Dynavax Technologies Director MacGregor Reports Stock and Option Transactions

Sentiment:

SEC Form 4 Filing


Director Brent MacGregor reports acquisition of restricted stock units and stock options in Dynavax Technologies.

Summary

  • On May 23, 2024, Brent MacGregor, a director of Dynavax Technologies Corp, reported acquiring 5,357 shares of common stock and disposing of 16,071 shares.
  • MacGregor also acquired 22,500 stock options with an exercise price of $11.85, exercisable from May 22, 2031.
  • The common stock was acquired as restricted stock units (RSUs) that vest one year from the grant date, contingent on continued service to the company.
  • The release of RSU shares is mandatorily deferred for six months and one day after the Reporting Person no longer provides services to the Company.
  • The option grant fully vests and becomes exercisable one year from the date of grant, provided that Reporting Person continues to provide services to the Company through such vesting date.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The director acquired RSUs and options, indicating confidence, but also disposed of some shares, which could raise concerns. The overall impact is likely minimal.

Positives

  • The acquisition of stock options and restricted stock units by a director signals confidence in the company's future performance.

Negatives

  • The disposal of 16,071 shares of common stock by a director could be interpreted negatively, although the acquisition of RSUs and options may offset this concern.

Risks

  • The vesting of RSUs and stock options is contingent on continued service to the company, creating a potential risk if the director leaves the company before the vesting date.
  • The mandatory deferral of RSU share release after service cessation could impact the director's liquidity.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to monitor potential alignment of interests between management and shareholders.

Stakeholder Impact

  • The transactions may have a minor impact on shareholder sentiment, depending on how the market interprets the director's actions.

Key Dates

DateDescription
05/23/2024Date of transaction for common stock and stock options
05/22/2031Expiration date of stock options
05/28/2024Date of signature for the report

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.